Clinical Guest Contributors

  1. Most Ex-U.S. Countries Can't Access The Medicines They Help Study 12/19/2025

    When a country hosts a clinical trial, we assume patients there will eventually benefit from the therapy they helped test. Research Jennifer E. Miller, Ph.D., says that's not often the case.

  2. More Patient Insight — And Funding— Needed To Advance Preeclampsia Research 12/18/2025

    Preeclampsia Foundation’s Laney Poye discusses the urgent need for sustained preeclampsia research funding, patient-informed trial design, and stronger partnerships between advocacy groups and biopharma. 

  3. What Is Win Ratio, And How Can It Be Used In Rare Disease Research? 12/17/2025

    Amber Salzman, CEO of Epicrispr Biotechnologies, explains how applying the win ratio in facioscapulohumeral muscular dystrophy (FSHD) could transform the way researchers evaluate therapeutic impact, enhance statistical efficiency, and improve trial design.

  4. Adaptive Trial Design Is Changing Oncology And Hematology Clinical Trials 12/16/2025

    Pfizer Global Development Lead, Clinical Development Oncology & Hematology, Shreya Badhrinarayanan, MD, explains how adaptive trials, enriched by AI and better data integration, are transforming oncology and hematology clinical research.

  5. Poland: An Underestimated Clinical Trials Powerhouse 12/15/2025

    Poland is not “one of the good options” or “an interesting emerging market," says Tomasz Szelag, head of clinical operations, Ryvu Therapeutics. Rather, it should be one of the first places sponsors look to run their clinical trials.

  6. Can't-Miss Advice On Selecting Your First AI-Enabled Vendor 12/12/2025

    Quarles & Brady's Simone Colgan Dunlap and Meghan O’Connor offer actionable guidance to help sponsor companies make informed, strategic choices in an evolving AI market.

  7. Clinical Supply's Role In Driving Success In Decentralized Trials 12/11/2025

    Decentralized trials are a challenge for supply chain professionals. Explore how logistics, labeling, and home delivery make or break trial outcomes.

  8. The 2020 Pediatric Mandate That Shook Up Oncology Research 12/11/2025

    Until 2020, the majority of drugs used in pediatric medicine had not been studied adequately in children. Regulatory expert Bhargavi Pandit recounts the impact the U.S. RACE for Children Act had on pediatric and adult investigational drug trials.

  9. The Site Perspective: Why Ambient AI Is The Missing Link In Clinical Trial Data Integrity 12/10/2025

    Discover how AI ambient listening has changed the way Mikel Daniels, DPM, MBA, and his team conduct clinical research at WeTreatFeet Podiatry. 

  10. Overcoming Cell Therapy Design Challenges To Treat AML And Other Life-Threatening Diseases 12/9/2025

    CERo CEO Chris Ehrlich discusses how a focus on safety, robust manufacturing, and key early indicators is rewriting the playbook for future personalized medicine trials.